Latest Period
Q1 2026
Security Snapshot
Adagene Inc. - Ordinary shares, par value USD $0.0001 per share (ADAG) Institutional Ownership
CUSIP: 005329107
13F Institutional Holders and Ownership History from Q1 2021 to Q1 2026
Institutions Reporting
24
Shares (Excl. Options)
1,957,086
Price
$3.92
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Ordinary shares, par value USD $0.0001 per share
- Symbol
- ADAG on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 1,957,086
- Total 13F value
- $7,671,396
- Portfolio coverage rank
- 0%
- Share change
- +208,783
- Value change
- +$1,211,474
- Number of holders
- 24
- Shares outstanding
- 83,843,205
- SEC-reported price per share
- $3.94
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- ADAG - Adagene Inc. - Ordinary shares, par value USD $0.0001 per share is tracked under CUSIP 005329107.
- 24 institutions reported positions in Q1 2026.
- 8 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 17 to 24 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $6,027,495 to $7,671,396.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 24 institutions filings for Q1 2026.
Security key
005329107
Latest holder period
Q1 2026
13F holders
24
13D/G owners
8
CIK / CUSIP context first
Open Q1 2026 holders
ADAG full holder history
Adagene Inc. SEC filings
Adagene Inc. company facts
Adagene Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 005329107:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
8
Security
ADAG
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Luo Peter | 11% | -27% | $34,369,007 | +$786,900 | 9,390,439 | +2.3% | HAN 2020 Irrevocable Trust | 05 Jun 2026 |
| JANUS HENDERSON GROUP PLC | 10% | $25,666,664 | 6,666,666 | JANUS HENDERSON GROUP PLC | 30 Apr 2026 | |||
| Smith Vincent C | 8.7% | +26% | $9,120,679 | +$2,258,166 | 5,095,351 | +33% | Smith Vincent C | 31 Dec 2025 |
| WuXi PharmaTech Healthcare Fund I L.P. | 7% | -17% | $8,187,161 | -$1,701,888 | 4,121,815 | -17% | WuXi PharmaTech Healthcare Fund I L.P. | 30 Sep 2025 |
| Chernett Jorey | 5.1% | $7,764,445 | 2,389,060 | Chernett Jorey | 16 Mar 2026 | |||
| Panacea Innovation Ltd | 3.8% | -28% | $4,469,175 | -$1,564,211 | 2,250,000 | -26% | Panacea Venture Healthcare Fund II, L.P. | 30 Sep 2025 |
| FIL Ltd | 1.8% | -75% | $1,320,902 | -$4,450,930 | 936,810 | -77% | FIL Limited | 31 Mar 2025 |
| FMR LLC | 0.9% | $933,679 | 473,949 | FMR LLC | 30 Jun 2025 |
As of 31 Mar 2026, 24 institutional investors reported holding 1,957,086 shares of Adagene Inc. - Ordinary shares, par value USD $0.0001 per share (ADAG). This represents 2.3% of the company’s total 83,843,205 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
21
Latest
Q1 2026
Rows shown
1-21 of 21
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 1,957,086 | $7,671,396 | +$1,211,474 | $3.92 | 24 |
| 2025 Q4 | 3,089,667 | $6,027,495 | -$5,437,806 | $1.89 | 17 |
| 2025 Q3 | 5,722,260 | $11,251,842 | -$681,939 | $1.99 | 17 |
| 2025 Q2 | 6,066,432 | $11,842,205 | -$2,692,639 | $1.95 | 15 |
| 2025 Q1 | 7,596,934 | $11,574,144 | -$4,448,523 | $1.54 | 13 |
| 2024 Q4 | 10,441,972 | $20,299,608 | +$6,443,398 | $1.99 | 15 |
| 2024 Q3 | 11,157,880 | $25,316,756 | -$140,637 | $2.22 | 13 |
| 2024 Q2 | 11,223,549 | $33,703,166 | -$3,006,648 | $3.06 | 14 |
| 2024 Q1 | 12,297,346 | $34,335,526 | +$14,585,257 | $2.80 | 17 |
| 2023 Q4 | 5,781,239 | $11,163,839 | -$2,205,992 | $1.93 | 10 |
| 2023 Q3 | 4,096,719 | $6,164,993 | -$21,756 | $1.53 | 10 |
| 2023 Q2 | 4,111,294 | $6,016,229 | -$108,766 | $1.48 | 10 |
| 2023 Q1 | 4,186,071 | $6,023,400 | -$44,708 | $1.45 | 11 |
| 2022 Q4 | 4,216,842 | $5,581,186 | -$2,280,668 | $1.32 | 9 |
| 2022 Q3 | 5,940,279 | $7,603,000 | -$2,338,985 | $1.28 | 11 |
| 2022 Q2 | 7,531,358 | $15,421,000 | -$3,922,354 | $2.03 | 15 |
| 2022 Q1 | 8,391,600 | $29,674,000 | -$1,196,241 | $3.56 | 15 |
| 2021 Q4 | 8,373,818 | $67,324,000 | -$5,705,274 | $8.01 | 16 |
| 2021 Q3 | 8,786,888 | $126,610,000 | +$41,051,156 | $14.37 | 19 |
| 2021 Q2 | 5,937,931 | $80,519,000 | -$12,766,604 | $13.56 | 16 |
| 2021 Q1 | 6,435,237 | $115,522,000 | +$115,522,000 | $17.95 | 27 |